Mother and baby's immune cells linked to aggressive placental inflammation in preterm cases

by Marta Wegorzewska, Washington University in St. Louis

edited by Gaby Clark, reviewed by Robert Egan

Gaby Clark

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add to Preferred Sources

In a healthy pregnancy, a finely tuned maternal immune response prevents the mother's body from rejecting the growing fetus. But in some pregnancies, this response goes haywire, leading to a potentially dangerous complication known as chronic placental inflammation. To understand what drives this inflammation, researchers led by Nardhy Gomez-Lopez, Ph.D., a professor of obstetrics and gynecology and of pathology and immunology at WashU Medicine, used spatial and single-cell gene and protein expression profiling to map the immune cell landscape of the placenta in mothers who developed chronic placental inflammation, down to individual cells at the junction connecting the mother and fetus.

Their findings were published Oct. 7 in Science Translational Medicine.

Comparing tissue samples from mothers with the complication who delivered prematurely to those who carried to full term, the team discovered that the preterm cases involved an aggressive inflammatory reaction driven by immune cells from both mother and baby, including cytotoxic T cells, activated macrophages and natural killer cells. In contrast, when women with the condition carried to full term, the placenta had a more harmonious immune environment, with a high volume of cells that help heal tissue and keep inflammation under control.

The researchers also discovered that T cells in the placenta samples had receptors—specialized proteins on the cell surface that recognize foreign or abnormal substances—that mimicked receptors known to recognize common viruses such as influenza. This suggests that past viral infections might mistakenly spark inflammation in the placenta.

Together, the findings lay the groundwork for simple blood tests to spot early warning signs of premature birth and new treatments to safeguard high-risk pregnancies.

Publication details

Dustyn Levenson et al., A multiomic atlas reveals distinct immune landscapes in preterm and term chronic placental inflammation, Science Translational Medicine (2026). DOI: 10.1126/scitranslmed.aee9049

Journal information: Science Translational Medicine

Key medical concepts

Premature BirthT-Lymphocytes, CytotoxicKiller Cells, Natural

Clinical categories

Obstetrics & gynecologyPregnancyAllergy and immunology Provided by Washington University in St. Louis Who's behind this story?

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Mother and baby's immune cells linked to aggressive placental inflammation in preterm cases (2026, November 6) retrieved 7 November 2026 from https://medicalxpress.com/news/2026-11-mother-baby-immune-cells-linked.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.